AC Immune SA vs. NVIDIA Corporation
NVIDIA Corporation (NVDA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ACIU | NVDA | |
|---|---|---|
| Market Cap | $255.53 million | $5.27 trillion |
| Revenue (TTM) | — | $253.49 billion |
| Net Income (TTM) | — | $159.61 billion |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| ACIU | NVDA | |
|---|---|---|
| P/E Ratio | — | 33.32 |
| Price / Book | — | 26.96 |
| Price / Sales | — | 20.79 |
ACIU and NVDA split the valuation factors evenly.
Profitability
| ACIU | NVDA | |
|---|---|---|
| Net Margin | — | 62.97% |
| Return on Equity | — | 81.65% |
ACIU and NVDA split the profitability factors evenly.
Dividend
| ACIU | NVDA | |
|---|---|---|
| Dividend Yield | — | 0.46% |
| Payout Ratio | — | 15.31 |
ACIU and NVDA split the dividend factors evenly.
Risk & Sentiment
| ACIU | NVDA | |
|---|---|---|
| Short Interest | 1.63% | 0.07% |
NVDA leads on 1 of 1 risk & sentiment factors.
Dig deeper: ACIU overview, ACIU financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.